Legato Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,674	Closed	-$279K	–	602
2024 Q2	$279K	Hold	23,674	–	–	0.04%	495
2024 Q1	$281K	Buy	+23,674	New	+$281K	0.03%	514
2021 Q3	–	Sell	-12,903	Closed	-$309K	–	263
2021 Q2	$309K	Buy	+12,903	New	+$309K	0.04%	321